NASDAQ
DMK Pharmaceuticals Corporation (DMKPQ) has a free cash flow growth of -45.50% as of Friday, May 29, 2026. This represents a 533.46% decrease compared to its 12-month average of 10.50%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.